Return
Company Page
Antiverse
Founders
Antiverse is an AI-driven techbio company specializing in de novo antibody design for challenging drug targets including G-protein coupled receptors (GPCRs) and ion channels. The company combines state-of-the-art machine learning with advanced cell line engineering and in-house laboratory validation through a lab-in-the-loop workflow to design therapeutic-strength antibodies for difficult targets involved in cancer, neurological disorders, and rare diseases.
Company Founded in 2017
Healthtech & Biotech